生长激素对重度宫腔黏连患者的治疗效果及对妊娠结局和炎性细胞因子的影响

摘要
图/表
参考文献(19)
相关文章 (4)

全文: PDF (630 KB) HTML (1 KB)
输出: BibTeX | EndNote (RIS)

摘要目的探讨生长激素对重度宫腔黏连患者的治疗效果及对妊娠结局和炎性细胞因子水平的影响。方法选取2014年6月~2017年3月右江民族医学院附属医院妇产科诊治的66例重度宫腔黏连患者为研究对象，按照是否使用生长激素将患者分为对照组（宫腔粘连分离术+雌激素治疗）+观察组（宫腔粘连分离术+雌激素+生长激素干预），每组各33例。比较两组患者的临床治疗效果和妊娠结局，应用酶联免疫吸附试验测定炎性细胞因子白细胞介素-6（IL-6）、白细胞介素-8（IL-8）和肿瘤坏死因子-α（TNF-α）的变化水平。结果观察组患者的月经改善率明显高于对照组（χ2=4.232，P=0.039），且宫腔再黏连率也明显低于对照组（χ2=3.995，P=0.046）；观察组患者的试孕成功率明显高于对照组（χ2=3.986，P=0.046），但两组不良反应发生率比较，差异无统计学意义（χ2=0.733， P=0.392）；观察组患者的子宫内膜厚度明显高于对照组（P < 0.05），但两组患者子宫内膜容积、阻力指数和搏动指数比较，差异无统计学意义（P > 0.05）。治疗后观察组患者的IL-6、IL-8和TNF-α水平均明显低于对照组，差异均有统计学意义（P < 0.05）。结论生长激素可显著提高宫腔黏连患者的治疗效果，改善妊娠结局，降低炎性细胞因子水平。

	服务

	把本文推荐给朋友
	加入我的书架
	加入引用管理器
	E-mail Alert
	RSS
	作者相关文章
	杨力吴惠珍甘海丝

关键词 ：生长激素, 重度宫腔黏连, 细胞因子, 妊娠结局

Abstract：Objective To investigate the effect of growth hormone on the treatment of patients with severe intrauterine adhesions and its effect on the outcome of pregnancy and the level of inflammatory cytokines. Methods Sixty-six patients with severe intrauterine adhesions treated in Obstetrics and Gynecology of Affiliated Hospital of Youjiang Medical University for Nationalities from June 2014 to March 2017 were selected as study subjects, and all patients were divided into control group (intrauterine adhesions separation surgery + estrogen therapy) + observation group (intrauterine adhesions separation + estrogen + growth hormone intervention) according to whether usedgrowth hormone, each group had 33 cases. The clinical treatment effect and pregnancy outcomes were compared between two groups, the levels of inflammatory cytokines interleukin-6 (IL-6), interleukin-8 (IL-8) and tumor necrosis factor-α (TNF-α) were measured by enzyme linked immunosorbent assay. Results The improvement rate of menstruation in the observation group was significantly higher than that in the control group (χ2=4.232, P=0.039), and the intrauterine readhesion rate was also significantly lower than that in the control group (χ2=3.995, P=0.046). The pregnancy success rate was significantly higher than that of the control group (χ2=3.986, P=0.046), but there was no significant difference in the incidence of adverse reactions between the two groups (χ2=0.733, P=0.392). The endometrial thickness of the observation group was significantly higher than that of the control group (P < 0.05). However, there was no significant difference in endometrial volume, resistance index and pulsatility index between the two groups (P > 0.05). In addition, the levels of IL-6, IL-8 and TNF-α in the observation group were significantly lower than those in the control group after the treatment (P < 0.05). Conclusion Growth hormone can significantly improve the treatment of patients with intrauterine adhesions, improve pregnancy outcomes, reduce the level of inflammatory cytokines.

Key words： Growth hormone Severe intrauterine adhesions Cytokines Pregnancy outcome

基金资助:广西高校中青年教师基础能力提升项目（KY2016 LX255）。

作者简介: 杨力（1983.7-），女，硕士；研究方向：生殖医学与围生医学。

引用本文:

杨力吴惠珍甘海丝. 生长激素对重度宫腔黏连患者的治疗效果及对妊娠结局和炎性细胞因子的影响[J]. 中国医药导报, 2018, 15(6): 84-87.
YANG Li WU Huizhen GAN Haisi. Effect of growth hormone in the treatment of patients with severe intrauterine adhesions and its effect on the outcome of pregnancy and the level of inflammatory cytokines. 中国医药导报, 2018, 15(6): 84-87.

链接本文:

http://www.yiyaodaobao.com.cn/CN/ 或 http://www.yiyaodaobao.com.cn/CN/Y2018/V15/I6/84

[1] Barel O，Krakov A，Pansky M，et al. Intrauterine adhesions after hysteroscopic treatment for retained products of conception：what are the risk factors? [J]. Fertility & Sterility，2015，103（3）：775-779.
[2] Hooker A，Fraenk D，Br?觟lmann H，et al. Prevalence of intrauterine adhesions after termination of pregnancy： a systematic review [J]. Eur J Contracept & Reproduct H C，2016，21（4）：329-335.
[3] Xiao S，Wan Y，Xue M，et al. Etiology，treatment，and reproductive prognosis of women with moderate-to-severe intrauterine adhesions [J]. Int J Gynaecol Obstet，2014， 125（2）：121-124.
[4] 施晓，杜玲，陈红球，等.透明质酸钠凝胶对人工流产术后宫腔粘连的预防价值[J].中国医药导报，2015，12（5）：44-47.
[5] 汤一群，段华，汪沙，等.中重度宫腔粘连术后妊娠率及其影响因素分析[J].中国计划生育和妇产科，2017，9（1）：37-41.
[6] Liu AZ，Zhao HG，Gao Y，et al. Effectiveness of estrogen treatment before transcervical resection of adhesions on moderate and severe uterine adhesion patients [J]. Gynecol Endocrinol，2016，32（9）：737-740.
[7] Lin XN，Zhou F，Wei ML，et al. Randomized，controlled trial comparing the efficacy of intrauterine balloon and intrauterine contraceptive device in the prevention of adhesion reformation after hysteroscopicadhesiolysis [J]. Fertility & Sterility，2015，104（1）：235-240.
[8] Barel O，Krakov A，Pansky M，et al. Intrauterine adhesions after hysteroscopic treatment for retained products of conception：what are the risk factors? [J]. Fertility & Sterility，2015，103（3）：775-779.
[9] Cai H，Lin Q，Song KJ，et al. Oxidized，regenerated cellulose adhesion barrier plus intrauterine device prevents recurrence after adhesiolysis for moderate to severe intrauterine adhesions [J]. J Minim Invasive Gynecol，2017， 24（1）：80-88.
[10] 罗成燕，邱江南，杨一君，等.不同剂量雌激素对重度宫腔黏连术后复发及月经的影响[J].中华妇幼临床医学杂志（电子版），2016，12（5）：558-565.
[11] 程丹，杨菁，李洁，等.促性腺激素释放激素类似物联合小剂量雌激素预防中、重度宫腔黏连复发的疗效分析[J].中华妇幼临床医学杂志：电子版，2017，13（4）：432-437.
[12] 张松菲.不同剂量雌激素在重度宫腔粘连术后预防再粘连的临床疗效观察[J].中国计划生育和妇产科，2016（2）：53-57.
[13] 李涛.宫腔黏连术后连续性或周期性雌激素对复发率、月经改善率及妊娠率的影响[J].实用临床医药杂志，2016， 20（11）：137-138.
[14] Cartersu C，Schwartz J，Argetsinger LS. Growth hormone signaling pathways.[J]. Growth Horm IGF Res，2016，28（4）：11-15.
[15] Fu Q，Mcknight RA，Callaway CW，et al. Intrauterine growth restriction disrupts developmental epigenetics around distal growth hormone response elements on the rat hepatic IGF-1 gene [J]. FASEB，2015，29（4）：1176-1184.
[16] Mcknight RA，Yost CC，Yu X，et al. Intrauterine growth restriction perturbs nucleosome depletion at a growth hormone responsive element in the mouse IGF-1 gene [J]. Physiol Genomics，2015，47（12）：634-643.
[17] 李杏婵，梁翠霞，李晶，等.宫腔黏连分离术联合生长激素对子宫内膜血流、容积及Smad2/3表达的影响[J].海南医学院学报，2016，22（19）：2309-2311.
[18] 杨金金.生长激素、山莨菪碱预防宫腔粘连分离术后再粘连的临床研究[D].郑州：郑州大学，2016.
[19] 祁玉娟，曹义娟，娄可欣，等.宫腔灌注生长激素有助于改善胚胎反复着床失败后冻融胚胎移植的妊娠结局[J].中国性科学，2017，26（9）：113-115.